Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Unknown 3Completed 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 5Breast 5Gastrointestinal 4Genitourinary 2Dermatologic 2

Conditions

Stomach Neoplasms 2Rectal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Adenocarcinoma of the Stomach 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × tesetaxel × Gastrointestinal × Clear all
NCT01573468 2012-07-24

TESEGAST

Genta Incorporated

Phase 2 Unknown
580 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00080834 2012-05-16

DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

Daiichi Sankyo

Phase 2 Completed
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01095120 2012-03-15

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Genta Incorporated

Phase 2 Unknown
27 enrolled
Gastrointestinal

Adenocarcinoma of the Stomach

NCT01348009 2012-03-13

Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer

Genta Incorporated

Phase 1/2 Unknown
63 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡